Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect.

Aims: To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy.

Methods: Ten eyes of 10 patients with acute central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.

Cancer-associated nummular loss of the retinal pigment epithelium.

Purpose: To report a case of cancer-associated nummular loss of the retinal pigment epithelium.

Methods: A 47-year-old man with a history of hepatocellular carcinoma presented with three weeks of bilateral visual loss. His best-corrected visual acuity was 20/40 in each eye.